Unnecessary diuretic therapy in the elderly. 1982

M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman

The possible beneficial or adverse effects of long-term diuretic use in the elderly were evaluated in 60 males (mean age 80.0 years) and 17 females (mean age 84.3 years). All subjects were found to have no obvious need for diuretics when initially assessed and were not receiving concurrent digoxin therapy. Residents were randomly allocated to placebo or active groups with stratification for prior hypertension or congestive heart failure (CHF) and they were followed for one year in a double-blind design. Mean BP, heart rate and weight at one year were similar to baseline values in both groups. Six active and two placebo subjects developed CHF and two other placebo subjects had a return of BP to hypertensive levels. Serum creatinine, cholesterol, potassium and BUN were significantly improved at one year in the placebo group. Chronic diuretic use did not alter appreciably the occurrence of CHF or hypertension in this elderly population and may not be necessary.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
June 1989, Comprehensive therapy,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
January 1986, Drugs,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
September 1978, Canadian Medical Association journal,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
January 1979, Canadian Medical Association journal,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
August 1995, Drugs & aging,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
April 2008, European journal of clinical pharmacology,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
November 1976, Irish medical journal,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
January 1986, Drugs,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
November 1986, Age and ageing,
M G Myers, and M E Weingert, and R H Fisher, and C I Gryfe, and H S Shulman
May 1972, Age and ageing,
Copied contents to your clipboard!